These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 16892376)

  • 1. Exploring metallodrug-protein interactions by ESI mass spectrometry: the reaction of anticancer platinum drugs with horse heart cytochrome c.
    Casini A; Gabbiani C; Mastrobuoni G; Messori L; Moneti G; Pieraccini G
    ChemMedChem; 2006 Apr; 1(4):413-7. PubMed ID: 16892376
    [No Abstract]   [Full Text] [Related]  

  • 2. Insights into the molecular mechanisms of protein platination from a case study: the reaction of anticancer platinum(II) iminoethers with horse heart cytochrome c.
    Casini A; Gabbiani C; Mastrobuoni G; Pellicani RZ; Intini FP; Arnesano F; Natile G; Moneti G; Francese S; Messori L
    Biochemistry; 2007 Oct; 46(43):12220-30. PubMed ID: 17924668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ESI mass spectrometry and X-ray diffraction studies of adducts between anticancer platinum drugs and hen egg white lysozyme.
    Casini A; Mastrobuoni G; Temperini C; Gabbiani C; Francese S; Moneti G; Supuran CT; Scozzafava A; Messori L
    Chem Commun (Camb); 2007 Jan; (2):156-8. PubMed ID: 17180231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gold(III) compounds as anticancer agents: relevance of gold-protein interactions for their mechanism of action.
    Casini A; Hartinger C; Gabbiani C; Mini E; Dyson PJ; Keppler BK; Messori L
    J Inorg Biochem; 2008 Mar; 102(3):564-75. PubMed ID: 18177942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biophysical characterisation of adducts formed between anticancer metallodrugs and selected proteins: new insights from X-ray diffraction and mass spectrometry studies.
    Casini A; Guerri A; Gabbiani C; Messori L
    J Inorg Biochem; 2008; 102(5-6):995-1006. PubMed ID: 18289690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein recognition of platinated DNA.
    Sadler PJ
    Chembiochem; 2009 Jan; 10(1):73-4. PubMed ID: 19040246
    [No Abstract]   [Full Text] [Related]  

  • 7. CE in anticancer metallodrug research--an update.
    Hartinger CG; Keppler BK
    Electrophoresis; 2007 Oct; 28(19):3436-46. PubMed ID: 17847132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrospray ionization mass spectrometry of platinum anticancer agents.
    Poon GK; Mistry P; Lewis S
    Biol Mass Spectrom; 1991 Nov; 20(11):687-92. PubMed ID: 1799578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solution behaviour and biomolecular interactions of two cytotoxic trans-platinum(II) complexes bearing aliphatic amine ligands.
    Cubo L; Casini A; Gabbiani C; Mastrobuoni G; Messori L; Jiménez-Barbero J; Navarro-Ranninger C; Quiroga AG
    Chemistry; 2009 Sep; 15(36):9139-46. PubMed ID: 19655350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of interactions between human serum albumin and tumor-inhibiting amino alcohol platinum(II) complexes using capillary electrophoresis.
    Aleksenko SS; Hartinger CG; Semenova O; Meelich K; Timerbaev AR; Keppler BK
    J Chromatogr A; 2007 Jul; 1155(2):218-21. PubMed ID: 17240384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactions of metallodrugs with proteins: selective binding of phosphane-based platinum(II) dichlorides to horse heart cytochrome c probed by ESI MS coupled to enzymatic cleavage.
    Mügge C; Michelucci E; Boscaro F; Gabbiani C; Messori L; Weigand W
    Metallomics; 2011 Oct; 3(10):987-90. PubMed ID: 21947338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ESI-MS characterisation of protein adducts of anticancer ruthenium(II)-arene PTA (RAPTA) complexes.
    Casini A; Mastrobuoni G; Ang WH; Gabbiani C; Pieraccini G; Moneti G; Dyson PJ; Messori L
    ChemMedChem; 2007 May; 2(5):631-5. PubMed ID: 17366652
    [No Abstract]   [Full Text] [Related]  

  • 13. Novel platinum(II)-based anticancer complexes and molecular hosts as their drug delivery vehicles.
    Wheate NJ; Taleb RI; Krause-Heuer AM; Cook RL; Wang S; Higgins VJ; Aldrich-Wright JR
    Dalton Trans; 2007 Nov; (43):5055-64. PubMed ID: 17992290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions between anticancer trans-platinum compounds and proteins: crystal structures and ESI-MS spectra of two protein adducts of trans-(dimethylamino)(methylamino)dichloridoplatinum(II).
    Messori L; Marzo T; Michelucci E; Russo Krauss I; Navarro-Ranninger C; Quiroga AG; Merlino A
    Inorg Chem; 2014 Aug; 53(15):7806-8. PubMed ID: 25025479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro cytotoxicity study on platinum (II) complexes with epoxysuccinates as leaving groups.
    Liu X; Shen H; Zhu H; Cui K; Gou S
    Bioorg Med Chem Lett; 2007 Jul; 17(14):3831-4. PubMed ID: 17533124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid separation and identification of phenolic and diterpenoid constituents from Radix Salvia miltiorrhizae by high-performance liquid chromatography diode-array detection, electrospray ionization time-of-flight mass spectrometry and electrospray ionization quadrupole ion trap mass spectrometry.
    Zhu Z; Zhang H; Zhao L; Dong X; Li X; Chai Y; Zhang G
    Rapid Commun Mass Spectrom; 2007; 21(12):1855-65. PubMed ID: 17510941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Size exclusion chromatography coupled to electrospray ionization mass spectrometry for analysis and quantitative characterization of arsenic interactions with peptides and proteins.
    Schmidt AC; Fahlbusch B; Otto M
    J Mass Spectrom; 2009 Jun; 44(6):898-910. PubMed ID: 19204972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transglutaminase-mediated PEGylation of proteins: direct identification of the sites of protein modification by mass spectrometry using a novel monodisperse PEG.
    Mero A; Spolaore B; Veronese FM; Fontana A
    Bioconjug Chem; 2009 Feb; 20(2):384-9. PubMed ID: 19186937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reaction of Zn7metallothionein with cis- and trans-[Pt(N-donor)2Cl2] anticancer complexes: trans-Pt(II) complexes retain their N-donor ligands.
    Knipp M; Karotki AV; Chesnov S; Natile G; Sadler PJ; Brabec V; Vasák M
    J Med Chem; 2007 Aug; 50(17):4075-86. PubMed ID: 17665893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent studies of the electrospray ionisation behaviour of selected drugs and their application in capillary electrophoresis-mass spectrometry and liquid chromatography-mass spectrometry.
    Smyth WF; Rodriguez V
    J Chromatogr A; 2007 Aug; 1159(1-2):159-74. PubMed ID: 17512938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.